Atlas Trials

Pazopanib Hydrochloride in Treating Patients With Recurrent or Persistent Uterine Cancer

Clinical trial NCT01247571 · COMPLETED

Trial details

NCT number
NCT01247571
Sponsor
National Cancer Institute (NCI)
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Recurrent Uterine Corpus SarcomaUterine Carcinosarcoma
Start date
2011-01-01
Primary completion
2016-01-01
Enrollment
22

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.